Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYear sort iconAgencyPenalty Amount
AstraZeneca PharmaceuticalsAstraZenecaoff-label or unapproved promotion of medical products2011MULTI-AG$68,500,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209
UCB Inc.UCBoff-label or unapproved promotion of medical products2011MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322
Elan Corporation PLCPerrigooff-label or unapproved promotion of medical products2010FDA$203,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010FDA$11,000,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$422,500,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010FDA$600,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010FDA$81,000,000
AstraZeneca LPAstraZenecaoff-label or unapproved promotion of medical products2010FDA$520,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$72,500,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000
AstraZeneca Pharmaceuticals LPAstraZenecaoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249
Elan Corp.Perrigooff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010AR-AG$18,500,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010MS-AG$18,500,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010LA-AG$20,000,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2010KY-AG$3,700,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009CT-AG$25,100,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009ID-AG$13,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2009KY-AG$661,860
Cephalon IncTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008FDA$425,000,000
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008FDA$4,000,000
Johnson & JohnsonJohnson & JohnsonControlled Substances Act violation2008USAO$511,000
Cephalon Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000
Cephalon, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008CT-AG$6,150,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2008MULTI-AG$62,000,000
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2008MULTI-AG$60,000,000
Advanced Neuromodulation Systems, Inc.Abbott LaboratoriesHHS civil monetary penalties2007HHSOIG$2,950,000
Bristol-Myers Squibb CompanyBristol-Myers Squibboff-label or unapproved promotion of medical products2007DOJ_CIVIL$515,000,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007DOJ_CIVIL$9,800,000
Jazz Pharmaceuticals Inc.Jazz Pharmaceuticalsoff-label or unapproved promotion of medical products2007USAO$20,000,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000
Purdue Frederick Company, Inc. and Purdue Pharma, L.P.Purdue PharmaControlled Substances Act violation2007NV-AG$1,047,787
Purdue PharmaPurdue Pharmaoff-label or unapproved promotion of medical products2007MULTI-AG$19,500,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006FDA$36,900,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006USAO$435,000,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000
Serono, S.A.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005FDA$704,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2005FDA$36,000,000
Serono Inc.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004FDA$430,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000
Genentech Inc.Rocheoff-label or unapproved promotion of medical products2000MULTI-AG$19,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.